Alnylam to webcast presentation at 41st annual j.p. morgan healthcare conference

Cambridge, mass.--( business wire )--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, announced today that management will present a company overview and participate in a q&a session at the 41st annual j.p. morgan healthcare conference on monday, january 9, 2023 at 9:45 am pt (12:45 pm et) at the westin st. francis in san francisco. this presentation will include an update on unaudited fourth quarter and full year 2022 global net product revenues.
ALNY Ratings Summary
ALNY Quant Ranking